Jane Street Group, LLC Kala Pharmaceuticals, Inc. Put Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 16, 2021	SELL	$2.62 - $5.43 $35,894 - $74,391	-13,700 Reduced 37.03%	23,300 $61,000
Q2 2021 Aug 16, 2021	SELL	$5.06 - $8.15 $73,876 - $118,990	-14,600 Reduced 28.29%	37,000 $196,000
Q1 2021 May 18, 2021	BUY	$6.24 - $9.58 $124,800 - $191,600	20,000 Added 63.29%	51,600 $348,000
Q4 2020 Feb 17, 2021	BUY	$6.28 - $8.79 $37,052 - $51,860	5,900 Added 22.96%	31,600 $214,000
Q2 2020 Aug 17, 2020	BUY	$8.33 - $13.79 $69,972 - $115,836	8,400 Added 48.55%	25,700 $270,000
Q1 2020 May 15, 2020	BUY	$3.83 - $8.79 $66,259 - $152,066	17,300 New	17,300 $152,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.74M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.